To address this urgent public health challenge, the COST Action Realising the therapeutic potential of novel cardioprotective therapies (EU-CARDIOPROTECTION), led by Professor Derek Hausenloy from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback